Previous 10 | Next 10 |
Accolade, Inc. (ACCD) Q4 2021 Results Conference Call May 05, 2021 04:30 PM ET Company Participants Todd Friedman - Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Conference Call Participants Michael Cher...
The following slide deck was published by Accolade, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Accolade, Inc. 2021 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Accolade, Inc. (NASDAQ: ACCD) Q4 2021 Earnings Call May 05, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Accolade, Inc. (ACCD) Q4 2021 Earnings Call Transcript
Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million Initiates guidance for...
Accolade (ACCD): Q4 GAAP EPS of -$1.72 misses by $1.62.Revenue of $59.2M beats by $2.72M.Initiates guidance for fiscal year 2022 revenue in the range of $260M to $265M, with Adjusted EBITDA in the range of $(38)M to $(42)MPress Release For further details see: Accolade EPS misses by $1....
Fiscal fourth quarter 2021 revenue of $59.2 million, a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million Fiscal year 2021 revenue of $170.4 million, a 29% increase compared to fiscal year 2020 revenue of $132.5 million Initiates guidance for...
Accolade (ACCD) agrees to acquire, a leading provider of virtual primary care and mental health consultant PlushCare.The deal value of ~$450M, consists of ~$40M in cash and $340M in common stock and an additional $70M of value payable upon the achievement of defined revenue mileston...
Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition. $200bn+ combined target addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and mana...
SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal...
Accolade has seen solid growth throughout the second half of 2020, now accompanied by some margin improvements as well. I like what I'm seeing as the company made a savvy deal as well at the start of this year. Shares look rather interesting to me here, certainly on a relative bas...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...